INS and type 2 diabetes mellitus: Type 2 diabetes mellitus (T2DM) is a highly prevalent (>400 million patients worldwide) metabolic disorder characterized by chronically elevated blood glucose resulting from systemic insulin resistance and impaired insulin secretion (WHO, 2023; Zheng et al., 2018).